Relative increases and decreases of RAD-treated cells in G0G1 and G2/M phases of the cell-cycle of HL and ALCL cells
. | Cell-cycle profiles . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
. | G0/G1, % . | . | S, % . | . | G2/M, % . | . | |||||
Cell line . | 0 nM . | 10 nM . | 0 nM . | 10 nM . | 0 nM . | 10 nM . | |||||
L540cy | 44 | 76 | 14 | 8 | 42 | 16 | |||||
L1236 | 45 | 73 | 13 | 11 | 42 | 16 | |||||
KM-H2 | 41 | 59 | 10 | 10 | 49 | 31 | |||||
L428 | 37 | 62 | 16 | 8 | 47 | 30 | |||||
HD-LM2 | 56 | 73 | 29 | 18 | 15 | 9 | |||||
Karpas 299 | 44 | 73 | 10 | 5 | 46 | 22 | |||||
FE-PD | 48 | 64 | 16 | 11 | 34 | 25 | |||||
JB6 | 32 | 52 | 15 | 10 | 53 | 38 | |||||
SU-DHL | 41 | 60 | 18 | 14 | 41 | 26 |
. | Cell-cycle profiles . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
. | G0/G1, % . | . | S, % . | . | G2/M, % . | . | |||||
Cell line . | 0 nM . | 10 nM . | 0 nM . | 10 nM . | 0 nM . | 10 nM . | |||||
L540cy | 44 | 76 | 14 | 8 | 42 | 16 | |||||
L1236 | 45 | 73 | 13 | 11 | 42 | 16 | |||||
KM-H2 | 41 | 59 | 10 | 10 | 49 | 31 | |||||
L428 | 37 | 62 | 16 | 8 | 47 | 30 | |||||
HD-LM2 | 56 | 73 | 29 | 18 | 15 | 9 | |||||
Karpas 299 | 44 | 73 | 10 | 5 | 46 | 22 | |||||
FE-PD | 48 | 64 | 16 | 11 | 34 | 25 | |||||
JB6 | 32 | 52 | 15 | 10 | 53 | 38 | |||||
SU-DHL | 41 | 60 | 18 | 14 | 41 | 26 |
Cell cycles of HL and ALCL cells were analyzed by propidium iodide staining and statistical analysis was performed via ModFit LT program. Untreated cells in G0/G1 and G2/M phase were set arbitrarily at 100% for each cell line.